The Fund seeks to achieve a combination of income and some capital growth.
Name | % Net Assets |
---|---|
BP | 7.7% |
Vodafone | 6.9% |
Royal Dutch Shell B | 6.7% |
HSBC | 6.5% |
Astrazeneca | 5.4% |
Glaxosmithkline | 4.7% |
National Grid | 3.8% |
British American Tobacco | 3.7% |
BAE Systems | 2.7% |
Aviva | 2.6% |
Key | % Net Assets |
---|---|
BP | 7.7% |
Vodafone | 6.9% |
Royal Dutch Shell B | 6.7% |
HSBC | 6.5% |
Other | 72.2% |
Date | 13-Nov-2024 |
---|---|
Bid | 800.20p |
Offer | 800.20p |
Currency | GBP |
Change | -6.80p |
% | -0.84% |
YTD change | 18.60p |
YTD % | 2.38% |
Fund Inception | 06/04/1984 |
---|---|
Fund Manager | Martin Cholwill |
TER | 1.34 (30-Sep-2010) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.10 |
You are here: research